Supporting treatment adherence for resilience and thriving (START): protocol for a mHealth randomized controlled trial.

ABSTRACT:

Background

Although behavioral interventions show some promise for reducing stimulant use and achieving durable viral suppression in sexual minority men (SMM) with HIV, scalable mHealth applications are needed to optimize their reach and cost-effectiveness.

Methods

Supporting Treatment Adherence for Resilience and Thriving (START) is a randomized controlled trial (RCT) testing the efficacy and cost-effectiveness of a mHealth application that integrates evidence-based positive affect regulation skills with self-monitoring of adherence and mood. The primary outcome is detectable HIV viral load (i.e., > 300 copies/mL) from self-collected dried blood spot (DBS) specimens at 6 months. Secondary outcomes include detectable DBS viral load at 12 months, self-reported stimulant use s

SUBMITTER: Davis-Ewart L 

PROVIDER: S-EPMC11360769 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature